Abstract:Lung cancer is the leading cause of cancer-related death. The five year survival rate had remained stagnant for decades, but more effective screening protocols using low-dose computed tomographic screening for high-risk individuals, along with progress in treatment for advanced-stage lung cancer with targeted therapy and immunotherapy, have helped decrease lung cancer mortality. However, improved approaches to lung cancer prevention and early detection are still urgently needed. Adenocarcinoma (LUAD) is the most common form of lung cancer. Following surgical resection of pre-invasive adenocarcinoma in situ, the five-year survival rate approaches 100%. This emphasizes the need for improved understanding of characteristics of aggressive premalignant lesions that would benefit from early interventions. In contrast to the well-characterized histopathologic sequence of lung squamous cell carcinoma, atypical adenomatous hyperplasia (AAH) and adenocarcinoma in situ (AIS) are the only known precursors in the sequence of LUAD pathogenesis. The features of AAH and AIS that lead to invasive LUAD are poorly characterized. The relationship of AIS and AAH to the histologically diverse subtypes of LUAD, ranging from the typically slow growing lepidic to aggressive solid subtypes, are also unclear. We hypothesized that transcriptomic changes in subsets of premalignant lesions are linked to distinct genomic and clinicopathologic features of malignant disease. To investigate this hypothesis, we performed exome sequencing and bulk RNA sequencing of laser capture microdissected tissue from tumor margins that included premalignant lesions, invasive tumor, and adjacent normal tissues. With our analysis, we discovered de novo subtypes of LUAD premalignant lesions based on gene expression. One of these subtypes had gene expression alterations similar to aggressive invasive LUAD solid tumors. This molecular adenomatous premalignant lesion subtype was also associated with an increased accumulation of cancer driver mutations. This subtype was further characterized by altered expression of immune-related pathways. Molecular signatures measured in adenomatous PML may thus enhance our understanding of pathway dysregulation and mutational heterogeneity occurring during LUAD carcinogenesis, and implicate immunotherapeutic strategies to prevent their progression to cancer. Citation Format: Kelley Anderson, Linh Tran, Kostyantyn Krysan, William Wallace, Gregory Fishbein, Emily Green, Gang Liu, Hanqiao Liu, Erin Kane, Sarah Mazzilli, Steven Dubinett, Avrum Spira, Marc Lenburg, Jennifer Beane. Molecular subtyping of lung adenocarcinoma premalignant lesions identifies features associated with aggressive disease [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2) nr PR007.

Genomic and Immune Profiling of Pre-Invasive Lung Adenocarcinoma.

Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study

Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.

Genomic landscape and tumor mutational features of resected preinvasive to invasive lung adenocarcinoma

Comprehensive Investigation of Mutational Features of Various Lung Adenocarcinoma Histological Subtypes among Chinese Patients.

Single-cell Evaluation Reveals Innate Immune Arrested and Lymphocytes Shifting That Promote Development of Preinvasive Lung Adenocarcinoma

Genomic Underpinnings of Tumor Behavior in in Situ and Early Lung Adenocarcinoma.

Immune microenvironment analysis and novel biomarkers of early-stage lung adenocarcinoma evolution

Distinct Mutational Features Across Preinvasive and Invasive Subtypes Identified Through Comprehensive Profiling of Surgically Resected Lung Adenocarcinoma.

Characterization of Evolution Trajectory and Immune Profiling of Brain Metastasis in Lung Adenocarcinoma

Identification Of Somatic Mutations In Non-Small Cell Lung Carcinomas Using Whole-Exome Sequencing

The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion

Abstract PR007: Molecular subtyping of lung adenocarcinoma premalignant lesions identifies features associated with aggressive disease

Up-regulated tumor intrinsic growth potential and decreased immune function orchestrate the evolution of lung adenocarcinoma

Evolution of DNA Methylome from Precancerous Lesions to Invasive Lung Adenocarcinomas

Integrative Proteomic Characterization of Human Lung Adenocarcinoma

An Investigation of the Immune Microenvironment and Genome During Lung Adenocarcinoma Development.

Comparative Study on the Mutational Profile of Adenocarcinoma and Squamous Cell Carcinoma Predominant Histologic Subtypes in Chinese Non‐small Cell Lung Cancer Patients

The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma

Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma

Evolution of DNA methylome from precancer to invasive lung adenocarcinoma